FILSUVEZ

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Romania, UK.

Active ingredients

The drug FILSUVEZ contains one active pharmaceutical ingredient (API):

1	Betulin UNII 6W70HN7X7O - BETULIN
	Betulin accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 μg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 µg/ml. The precise mechanism of action of the active substance in wound healing in humans is not known.
	Read more about Betulin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FILSUVEZ Gel	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D03AX13		D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3049196, 3049208, 3049219, 3049220, 3049231
FR	Base de données publique des médicaments	60528073
IT	Agenzia del Farmaco	050219017, 050219029, 050219031, 050219043, 050219056
LT	Valstybinė vaistų kontrolės tarnyba	1095021, 1095022
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69224001, W69224002